HEADER TRANSFERASE/TRANSFERASE INHIBITOR 25-FEB-21 7LVH TITLE CRYSTAL STRUCTURE OF AP2 ASSOCIATED KINASE 1 ISOFORM 1 COMPLEXED WITH TITLE 2 LIGAND N-[3-METHOXY-4-(1,3-OXAZOL-5-YL)PHENYL]-3-(PROPAN-2-YL) TITLE 3 PIPERIDINE-2-CARBOXAMIDE COMPND MOL_ID: 1; COMPND 2 MOLECULE: AP2-ASSOCIATED PROTEIN KINASE 1; COMPND 3 CHAIN: A, B; COMPND 4 SYNONYM: ADAPTOR-ASSOCIATED KINASE 1; COMPND 5 EC: 2.7.11.1; COMPND 6 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: MUS MUSCULUS; SOURCE 3 ORGANISM_COMMON: MOUSE; SOURCE 4 ORGANISM_TAXID: 10090; SOURCE 5 GENE: AAK1, KIAA1048; SOURCE 6 EXPRESSION_SYSTEM: ESCHERICHIA COLI BL21(DE3); SOURCE 7 EXPRESSION_SYSTEM_TAXID: 469008 KEYWDS KINASE, AAK1, LIGAND, TRANSFERASE, TRANSFERASE-TRANSFERASE INHIBITOR KEYWDS 2 COMPLEX EXPDTA X-RAY DIFFRACTION AUTHOR J.K.MUCKELBAUER REVDAT 5 03-APR-24 7LVH 1 REMARK REVDAT 4 25-AUG-21 7LVH 1 JRNL REVDAT 3 11-AUG-21 7LVH 1 REMARK REVDAT 2 04-AUG-21 7LVH 1 JRNL REVDAT 1 28-JUL-21 7LVH 0 JRNL AUTH R.A.HARTZ,V.T.AHUJA,S.J.NARA,C.M.V.KUMAR,J.M.BROWN, JRNL AUTH 2 L.J.BRISTOW,R.RAJAMANI,J.K.MUCKELBAUER,D.CAMAC,S.E.KIEFER, JRNL AUTH 3 L.HUNIHAN,M.GULIANELLO,M.LEWIS,A.EASTON,J.S.LIPPY,N.SURTI, JRNL AUTH 4 S.N.PATTIPATI,M.DOKANIA,S.ELAVAZHAGAN,K.DANDAPANI, JRNL AUTH 5 B.D.HAMMAN,J.ALLEN,W.KOSTICH,J.J.BRONSON,J.E.MACOR, JRNL AUTH 6 C.D.DZIERBA JRNL TITL DISCOVERY, STRUCTURE-ACTIVITY RELATIONSHIPS, AND IN VIVO JRNL TITL 2 EVALUATION OF NOVEL ARYL AMIDES AS BRAIN PENETRANT ADAPTOR JRNL TITL 3 PROTEIN 2-ASSOCIATED KINASE 1 (AAK1) INHIBITORS FOR THE JRNL TITL 4 TREATMENT OF NEUROPATHIC PAIN. JRNL REF J.MED.CHEM. V. 64 11090 2021 JRNL REFN ISSN 0022-2623 JRNL PMID 34270254 JRNL DOI 10.1021/ACS.JMEDCHEM.1C00472 REMARK 2 REMARK 2 RESOLUTION. 2.65 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : BUSTER 2.11.5 REMARK 3 AUTHORS : BRICOGNE,BLANC,BRANDL,FLENSBURG,KELLER, REMARK 3 : PACIOREK,ROVERSI,SHARFF,SMART,VONRHEIN, REMARK 3 : WOMACK,MATTHEWS,TEN EYCK,TRONRUD REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.65 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 30.67 REMARK 3 DATA CUTOFF (SIGMA(F)) : 0.000 REMARK 3 COMPLETENESS FOR RANGE (%) : 100.0 REMARK 3 NUMBER OF REFLECTIONS : 24905 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING + TEST SET) : 0.267 REMARK 3 R VALUE (WORKING SET) : 0.265 REMARK 3 FREE R VALUE : 0.299 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 5.090 REMARK 3 FREE R VALUE TEST SET COUNT : 1267 REMARK 3 ESTIMATED ERROR OF FREE R VALUE : NULL REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : 13 REMARK 3 BIN RESOLUTION RANGE HIGH (ANGSTROMS) : 2.65 REMARK 3 BIN RESOLUTION RANGE LOW (ANGSTROMS) : 2.76 REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : 99.95 REMARK 3 REFLECTIONS IN BIN (WORKING + TEST SET) : 2763 REMARK 3 BIN R VALUE (WORKING + TEST SET) : 0.2714 REMARK 3 REFLECTIONS IN BIN (WORKING SET) : 2647 REMARK 3 BIN R VALUE (WORKING SET) : 0.2679 REMARK 3 BIN FREE R VALUE : 0.3472 REMARK 3 BIN FREE R VALUE TEST SET SIZE (%) : 4.20 REMARK 3 BIN FREE R VALUE TEST SET COUNT : 116 REMARK 3 ESTIMATED ERROR OF BIN FREE R VALUE : 0.000 REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 4181 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 64 REMARK 3 SOLVENT ATOMS : 11 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : 76.94 REMARK 3 MEAN B VALUE (OVERALL, A**2) : 59.96 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : 2.59420 REMARK 3 B22 (A**2) : 2.59420 REMARK 3 B33 (A**2) : -5.18850 REMARK 3 B12 (A**2) : 0.00000 REMARK 3 B13 (A**2) : 0.00000 REMARK 3 B23 (A**2) : 0.00000 REMARK 3 REMARK 3 ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM LUZZATI PLOT (A) : 0.488 REMARK 3 DPI (BLOW EQ-10) BASED ON R VALUE (A) : 0.507 REMARK 3 DPI (BLOW EQ-9) BASED ON FREE R VALUE (A) : 0.321 REMARK 3 DPI (CRUICKSHANK) BASED ON R VALUE (A) : 0.520 REMARK 3 DPI (CRUICKSHANK) BASED ON FREE R VALUE (A) : 0.326 REMARK 3 REMARK 3 REFERENCES: BLOW, D. (2002) ACTA CRYST D58, 792-797 REMARK 3 CRUICKSHANK, D.W.J. (1999) ACTA CRYST D55, 583-601 REMARK 3 REMARK 3 CORRELATION COEFFICIENTS. REMARK 3 CORRELATION COEFFICIENT FO-FC : 0.902 REMARK 3 CORRELATION COEFFICIENT FO-FC FREE : 0.875 REMARK 3 REMARK 3 NUMBER OF GEOMETRIC FUNCTION TERMS DEFINED : 15 REMARK 3 TERM COUNT WEIGHT FUNCTION. REMARK 3 BOND LENGTHS : 4372 ; 2.000 ; HARMONIC REMARK 3 BOND ANGLES : 5986 ; 2.000 ; HARMONIC REMARK 3 TORSION ANGLES : 1391 ; 2.000 ; SINUSOIDAL REMARK 3 TRIGONAL CARBON PLANES : 95 ; 2.000 ; HARMONIC REMARK 3 GENERAL PLANES : 688 ; 5.000 ; HARMONIC REMARK 3 ISOTROPIC THERMAL FACTORS : 4372 ; 20.000 ; HARMONIC REMARK 3 BAD NON-BONDED CONTACTS : NULL ; NULL ; NULL REMARK 3 IMPROPER TORSIONS : NULL ; NULL ; NULL REMARK 3 PSEUDOROTATION ANGLES : NULL ; NULL ; NULL REMARK 3 CHIRAL IMPROPER TORSION : 590 ; 5.000 ; SEMIHARMONIC REMARK 3 SUM OF OCCUPANCIES : NULL ; NULL ; NULL REMARK 3 UTILITY DISTANCES : NULL ; NULL ; NULL REMARK 3 UTILITY ANGLES : NULL ; NULL ; NULL REMARK 3 UTILITY TORSION : NULL ; NULL ; NULL REMARK 3 IDEAL-DIST CONTACT TERM : 4728 ; 4.000 ; SEMIHARMONIC REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES. REMARK 3 BOND LENGTHS (A) : 0.010 REMARK 3 BOND ANGLES (DEGREES) : 1.17 REMARK 3 PEPTIDE OMEGA TORSION ANGLES (DEGREES) : 2.85 REMARK 3 OTHER TORSION ANGLES (DEGREES) : 19.23 REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 7LVH COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 26-FEB-21. REMARK 100 THE DEPOSITION ID IS D_1000255073. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 18-DEC-09 REMARK 200 TEMPERATURE (KELVIN) : 100.000 REMARK 200 PH : 5.5 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : APS REMARK 200 BEAMLINE : 17-ID REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 1 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : CCD REMARK 200 DETECTOR MANUFACTURER : ADSC QUANTUM 210 REMARK 200 INTENSITY-INTEGRATION SOFTWARE : D*TREK REMARK 200 DATA SCALING SOFTWARE : D*TREK 9.9.3L REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 24933 REMARK 200 RESOLUTION RANGE HIGH (A) : 2.650 REMARK 200 RESOLUTION RANGE LOW (A) : 46.480 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : NULL REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 100.0 REMARK 200 DATA REDUNDANCY : 10.70 REMARK 200 R MERGE (I) : NULL REMARK 200 R SYM (I) : 0.09200 REMARK 200 FOR THE DATA SET : 10.9000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 2.65 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 2.74 REMARK 200 COMPLETENESS FOR SHELL (%) : 100.0 REMARK 200 DATA REDUNDANCY IN SHELL : 11.00 REMARK 200 R MERGE FOR SHELL (I) : NULL REMARK 200 R SYM FOR SHELL (I) : 0.51400 REMARK 200 FOR SHELL : 3.300 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: MOLREP REMARK 200 STARTING MODEL: IN-HOUSE MODEL REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 57.47 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.89 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 0.9 M AMMONIUM SULFATE, 0.14 M SODIUM REMARK 280 CHLORIDE, 0.1 M BIS-TRIS PH 5.5, AND 1% PEG 3350, VAPOR REMARK 280 DIFFUSION, HANGING DROP, TEMPERATURE 295K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 31 2 1 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -Y,X-Y,Z+1/3 REMARK 290 3555 -X+Y,-X,Z+2/3 REMARK 290 4555 Y,X,-Z REMARK 290 5555 X-Y,-Y,-Z+2/3 REMARK 290 6555 -X,-X+Y,-Z+1/3 REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -0.500000 -0.866025 0.000000 0.00000 REMARK 290 SMTRY2 2 0.866025 -0.500000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 57.38167 REMARK 290 SMTRY1 3 -0.500000 0.866025 0.000000 0.00000 REMARK 290 SMTRY2 3 -0.866025 -0.500000 0.000000 0.00000 REMARK 290 SMTRY3 3 0.000000 0.000000 1.000000 114.76333 REMARK 290 SMTRY1 4 -0.500000 0.866025 0.000000 0.00000 REMARK 290 SMTRY2 4 0.866025 0.500000 0.000000 0.00000 REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000 REMARK 290 SMTRY1 5 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 5 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 5 0.000000 0.000000 -1.000000 114.76333 REMARK 290 SMTRY1 6 -0.500000 -0.866025 0.000000 0.00000 REMARK 290 SMTRY2 6 -0.866025 0.500000 0.000000 0.00000 REMARK 290 SMTRY3 6 0.000000 0.000000 -1.000000 57.38167 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1, 2 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: MONOMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 REMARK 350 BIOMOLECULE: 2 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: MONOMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 APPLY THE FOLLOWING TO CHAINS: B REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 MET A 13 REMARK 465 HIS A 14 REMARK 465 HIS A 15 REMARK 465 HIS A 16 REMARK 465 HIS A 17 REMARK 465 HIS A 18 REMARK 465 HIS A 19 REMARK 465 LEU A 20 REMARK 465 VAL A 21 REMARK 465 PRO A 22 REMARK 465 ARG A 23 REMARK 465 GLY A 24 REMARK 465 SER A 25 REMARK 465 SER A 26 REMARK 465 SER A 27 REMARK 465 SER A 28 REMARK 465 GLY A 29 REMARK 465 LEU A 30 REMARK 465 GLY A 31 REMARK 465 SER A 32 REMARK 465 GLY A 33 REMARK 465 SER A 98 REMARK 465 SER A 115 REMARK 465 SER A 116 REMARK 465 GLY A 117 REMARK 465 ASP A 118 REMARK 465 VAL A 119 REMARK 465 LYS A 169 REMARK 465 ASP A 186 REMARK 465 ARG A 187 REMARK 465 GLN A 206 REMARK 465 ALA A 207 REMARK 465 ILE A 329 REMARK 465 PRO A 330 REMARK 465 MET B 13 REMARK 465 HIS B 14 REMARK 465 HIS B 15 REMARK 465 HIS B 16 REMARK 465 HIS B 17 REMARK 465 HIS B 18 REMARK 465 HIS B 19 REMARK 465 LEU B 20 REMARK 465 VAL B 21 REMARK 465 PRO B 22 REMARK 465 ARG B 23 REMARK 465 GLY B 24 REMARK 465 SER B 25 REMARK 465 SER B 26 REMARK 465 SER B 27 REMARK 465 SER B 28 REMARK 465 GLY B 29 REMARK 465 LEU B 30 REMARK 465 GLY B 31 REMARK 465 SER B 32 REMARK 465 GLY B 33 REMARK 465 TYR B 34 REMARK 465 SER B 98 REMARK 465 SER B 115 REMARK 465 SER B 116 REMARK 465 GLY B 117 REMARK 465 ASP B 118 REMARK 465 LYS B 169 REMARK 465 THR B 170 REMARK 465 ASP B 186 REMARK 465 ARG B 187 REMARK 465 GLN B 206 REMARK 465 ALA B 207 REMARK 465 LYS B 237 REMARK 465 ILE B 238 REMARK 465 ARG B 281 REMARK 465 PRO B 330 REMARK 470 REMARK 470 MISSING ATOM REMARK 470 THE FOLLOWING RESIDUES HAVE MISSING ATOMS (M=MODEL NUMBER; REMARK 470 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; REMARK 470 I=INSERTION CODE): REMARK 470 M RES CSSEQI ATOMS REMARK 470 ARG A 43 CG CD NE CZ NH1 NH2 REMARK 470 GLN A 44 CG CD OE1 NE2 REMARK 470 GLU A 54 CG CD OE1 OE2 REMARK 470 PHE A 57 CG CD1 CD2 CE1 CE2 CZ REMARK 470 LYS A 88 CG CD CE NZ REMARK 470 ARG A 89 CG CD NE CZ NH1 NH2 REMARK 470 GLN A 92 CG CD OE1 NE2 REMARK 470 ARG A 95 CG CD NE CZ NH1 NH2 REMARK 470 LEU A 97 CG CD1 CD2 REMARK 470 LYS A 101 CG CD CE NZ REMARK 470 VAL A 114 CG1 CG2 REMARK 470 ARG A 130 CG CD NE CZ NH1 NH2 REMARK 470 GLN A 133 CG CD OE1 NE2 REMARK 470 ASN A 136 CG OD1 ND2 REMARK 470 GLN A 140 CG CD OE1 NE2 REMARK 470 LEU A 142 CG CD1 CD2 REMARK 470 GLN A 143 CG CD OE1 NE2 REMARK 470 GLN A 153 CG CD OE1 NE2 REMARK 470 ARG A 164 NE CZ NH1 NH2 REMARK 470 GLN A 167 CG CD OE1 NE2 REMARK 470 HIS A 185 CG ND1 CD2 CE1 NE2 REMARK 470 LYS A 201 CE NZ REMARK 470 GLU A 208 CG CD OE1 OE2 REMARK 470 LYS A 218 CD CE NZ REMARK 470 LYS A 219 CD CE NZ REMARK 470 LYS A 237 CD CE NZ REMARK 470 LEU A 251 CG CD1 CD2 REMARK 470 ILE A 276 CG1 CG2 CD1 REMARK 470 ASP A 278 CG OD1 OD2 REMARK 470 ASN A 279 CG OD1 ND2 REMARK 470 ARG A 281 CG CD NE CZ NH1 NH2 REMARK 470 ARG A 291 CG CD NE CZ NH1 NH2 REMARK 470 LYS A 300 CG CD CE NZ REMARK 470 VAL A 307 CG1 CG2 REMARK 470 PHE A 310 CG CD1 CD2 CE1 CE2 CZ REMARK 470 SER A 311 OG REMARK 470 LYS A 313 CD CE NZ REMARK 470 LEU A 315 CG CD1 CD2 REMARK 470 LYS A 316 CG CD CE NZ REMARK 470 LYS A 317 CD CE NZ REMARK 470 GLU A 318 CG CD OE1 OE2 REMARK 470 VAL A 321 CG1 CG2 REMARK 470 ASN A 323 CG OD1 ND2 REMARK 470 VAL A 324 CG1 CG2 REMARK 470 GLN A 325 CG CD OE1 NE2 REMARK 470 ASN A 326 CG OD1 ND2 REMARK 470 SER A 327 OG REMARK 470 ARG B 37 CG CD NE CZ NH1 NH2 REMARK 470 ARG B 43 CG CD NE CZ NH1 NH2 REMARK 470 ASN B 67 CG OD1 ND2 REMARK 470 GLU B 81 CG CD OE1 OE2 REMARK 470 HIS B 82 CG ND1 CD2 CE1 NE2 REMARK 470 LEU B 84 CG CD1 CD2 REMARK 470 GLN B 85 CG CD OE1 NE2 REMARK 470 VAL B 86 CG1 CG2 REMARK 470 LYS B 88 CG CD CE NZ REMARK 470 ARG B 89 CG CD NE CZ NH1 NH2 REMARK 470 GLN B 92 CG CD OE1 NE2 REMARK 470 ARG B 95 CG CD NE CZ NH1 NH2 REMARK 470 LEU B 97 CG CD1 CD2 REMARK 470 ASN B 112 CG OD1 ND2 REMARK 470 VAL B 114 CG1 CG2 REMARK 470 GLN B 140 CG CD OE1 NE2 REMARK 470 LEU B 142 CG CD1 CD2 REMARK 470 GLN B 143 CG CD OE1 NE2 REMARK 470 ARG B 164 CG CD NE CZ NH1 NH2 REMARK 470 ILE B 172 CG1 CG2 CD1 REMARK 470 ILE B 182 CD1 REMARK 470 HIS B 185 CG ND1 CD2 CE1 NE2 REMARK 470 ASN B 200 CG OD1 ND2 REMARK 470 LYS B 201 CG CD CE NZ REMARK 470 GLN B 203 CG CD OE1 NE2 REMARK 470 GLU B 208 CG CD OE1 OE2 REMARK 470 VAL B 213 CG1 CG2 REMARK 470 GLU B 214 CG CD OE1 OE2 REMARK 470 ASP B 215 CG OD1 OD2 REMARK 470 GLU B 216 CG CD OE1 OE2 REMARK 470 LYS B 218 CD CE NZ REMARK 470 LYS B 219 CD CE NZ REMARK 470 LEU B 233 CG CD1 CD2 REMARK 470 TYR B 234 CG CD1 CD2 CE1 CE2 CZ OH REMARK 470 SER B 235 OG REMARK 470 GLN B 284 CD OE1 NE2 REMARK 470 ARG B 291 CG CD NE CZ NH1 NH2 REMARK 470 LYS B 300 CG CD CE NZ REMARK 470 LYS B 317 CD CE NZ REMARK 470 GLU B 318 CG CD OE1 OE2 REMARK 470 ILE B 329 CG1 CG2 CD1 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 ARG A 43 -55.81 78.96 REMARK 500 ARG A 175 -3.41 66.70 REMARK 500 ASP A 176 40.11 -144.49 REMARK 500 CYS A 193 -147.30 -99.27 REMARK 500 ASP A 194 114.80 14.04 REMARK 500 TYR A 234 35.87 -98.15 REMARK 500 LYS A 237 85.80 60.02 REMARK 500 THR A 240 -169.40 -120.65 REMARK 500 ARG A 281 -36.93 89.35 REMARK 500 ARG B 43 -51.15 78.07 REMARK 500 ARG B 175 -2.89 66.46 REMARK 500 ASP B 176 40.10 -144.27 REMARK 500 ASP B 194 102.90 52.70 REMARK 500 TYR B 234 35.77 -97.91 REMARK 500 THR B 240 -169.16 -119.98 REMARK 500 REMARK 500 REMARK: NULL REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue YFS A 401 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue SO4 A 402 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC3 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue YFV B 401 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC4 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue SO4 B 402 DBREF 7LVH A 26 330 UNP Q3UHJ0 AAK1_MOUSE 26 330 DBREF 7LVH B 26 330 UNP Q3UHJ0 AAK1_MOUSE 26 330 SEQADV 7LVH MET A 13 UNP Q3UHJ0 INITIATING METHIONINE SEQADV 7LVH HIS A 14 UNP Q3UHJ0 EXPRESSION TAG SEQADV 7LVH HIS A 15 UNP Q3UHJ0 EXPRESSION TAG SEQADV 7LVH HIS A 16 UNP Q3UHJ0 EXPRESSION TAG SEQADV 7LVH HIS A 17 UNP Q3UHJ0 EXPRESSION TAG SEQADV 7LVH HIS A 18 UNP Q3UHJ0 EXPRESSION TAG SEQADV 7LVH HIS A 19 UNP Q3UHJ0 EXPRESSION TAG SEQADV 7LVH LEU A 20 UNP Q3UHJ0 EXPRESSION TAG SEQADV 7LVH VAL A 21 UNP Q3UHJ0 EXPRESSION TAG SEQADV 7LVH PRO A 22 UNP Q3UHJ0 EXPRESSION TAG SEQADV 7LVH ARG A 23 UNP Q3UHJ0 EXPRESSION TAG SEQADV 7LVH GLY A 24 UNP Q3UHJ0 EXPRESSION TAG SEQADV 7LVH SER A 25 UNP Q3UHJ0 EXPRESSION TAG SEQADV 7LVH MET B 13 UNP Q3UHJ0 INITIATING METHIONINE SEQADV 7LVH HIS B 14 UNP Q3UHJ0 EXPRESSION TAG SEQADV 7LVH HIS B 15 UNP Q3UHJ0 EXPRESSION TAG SEQADV 7LVH HIS B 16 UNP Q3UHJ0 EXPRESSION TAG SEQADV 7LVH HIS B 17 UNP Q3UHJ0 EXPRESSION TAG SEQADV 7LVH HIS B 18 UNP Q3UHJ0 EXPRESSION TAG SEQADV 7LVH HIS B 19 UNP Q3UHJ0 EXPRESSION TAG SEQADV 7LVH LEU B 20 UNP Q3UHJ0 EXPRESSION TAG SEQADV 7LVH VAL B 21 UNP Q3UHJ0 EXPRESSION TAG SEQADV 7LVH PRO B 22 UNP Q3UHJ0 EXPRESSION TAG SEQADV 7LVH ARG B 23 UNP Q3UHJ0 EXPRESSION TAG SEQADV 7LVH GLY B 24 UNP Q3UHJ0 EXPRESSION TAG SEQADV 7LVH SER B 25 UNP Q3UHJ0 EXPRESSION TAG SEQRES 1 A 318 MET HIS HIS HIS HIS HIS HIS LEU VAL PRO ARG GLY SER SEQRES 2 A 318 SER SER SER GLY LEU GLY SER GLY TYR ILE GLY ARG VAL SEQRES 3 A 318 PHE GLY ILE GLY ARG GLN GLN VAL THR VAL ASP GLU VAL SEQRES 4 A 318 LEU ALA GLU GLY GLY PHE ALA LEU VAL PHE LEU VAL ARG SEQRES 5 A 318 THR SER ASN GLY VAL LYS CYS ALA LEU LYS ARG MET PHE SEQRES 6 A 318 VAL ASN ASN GLU HIS ASP LEU GLN VAL CYS LYS ARG GLU SEQRES 7 A 318 ILE GLN ILE MET ARG ASP LEU SER GLY HIS LYS ASN ILE SEQRES 8 A 318 VAL GLY TYR ILE ASP SER SER ILE ASN ASN VAL SER SER SEQRES 9 A 318 GLY ASP VAL TRP GLU VAL LEU ILE LEU MET ASP PHE CYS SEQRES 10 A 318 ARG GLY GLY GLN VAL VAL ASN LEU MET ASN GLN ARG LEU SEQRES 11 A 318 GLN THR GLY PHE THR GLU ASN GLU VAL LEU GLN ILE PHE SEQRES 12 A 318 CYS ASP THR CYS GLU ALA VAL ALA ARG LEU HIS GLN CYS SEQRES 13 A 318 LYS THR PRO ILE ILE HIS ARG ASP LEU LYS VAL GLU ASN SEQRES 14 A 318 ILE LEU LEU HIS ASP ARG GLY HIS TYR VAL LEU CYS ASP SEQRES 15 A 318 PHE GLY SER ALA THR ASN LYS PHE GLN ASN PRO GLN ALA SEQRES 16 A 318 GLU GLY VAL ASN ALA VAL GLU ASP GLU ILE LYS LYS TYR SEQRES 17 A 318 THR THR LEU SER TYR ARG ALA PRO GLU MET VAL ASN LEU SEQRES 18 A 318 TYR SER GLY LYS ILE ILE THR THR LYS ALA ASP ILE TRP SEQRES 19 A 318 ALA LEU GLY CYS LEU LEU TYR LYS LEU CYS TYR PHE THR SEQRES 20 A 318 LEU PRO PHE GLY GLU SER GLN VAL ALA ILE CYS ASP GLY SEQRES 21 A 318 SER PHE THR ILE PRO ASP ASN SER ARG TYR SER GLN ASP SEQRES 22 A 318 MET HIS CYS LEU ILE ARG TYR MET LEU GLU PRO ASP PRO SEQRES 23 A 318 ASP LYS ARG PRO ASP ILE TYR GLN VAL SER TYR PHE SER SEQRES 24 A 318 PHE LYS LEU LEU LYS LYS GLU CYS PRO VAL PRO ASN VAL SEQRES 25 A 318 GLN ASN SER PRO ILE PRO SEQRES 1 B 318 MET HIS HIS HIS HIS HIS HIS LEU VAL PRO ARG GLY SER SEQRES 2 B 318 SER SER SER GLY LEU GLY SER GLY TYR ILE GLY ARG VAL SEQRES 3 B 318 PHE GLY ILE GLY ARG GLN GLN VAL THR VAL ASP GLU VAL SEQRES 4 B 318 LEU ALA GLU GLY GLY PHE ALA LEU VAL PHE LEU VAL ARG SEQRES 5 B 318 THR SER ASN GLY VAL LYS CYS ALA LEU LYS ARG MET PHE SEQRES 6 B 318 VAL ASN ASN GLU HIS ASP LEU GLN VAL CYS LYS ARG GLU SEQRES 7 B 318 ILE GLN ILE MET ARG ASP LEU SER GLY HIS LYS ASN ILE SEQRES 8 B 318 VAL GLY TYR ILE ASP SER SER ILE ASN ASN VAL SER SER SEQRES 9 B 318 GLY ASP VAL TRP GLU VAL LEU ILE LEU MET ASP PHE CYS SEQRES 10 B 318 ARG GLY GLY GLN VAL VAL ASN LEU MET ASN GLN ARG LEU SEQRES 11 B 318 GLN THR GLY PHE THR GLU ASN GLU VAL LEU GLN ILE PHE SEQRES 12 B 318 CYS ASP THR CYS GLU ALA VAL ALA ARG LEU HIS GLN CYS SEQRES 13 B 318 LYS THR PRO ILE ILE HIS ARG ASP LEU LYS VAL GLU ASN SEQRES 14 B 318 ILE LEU LEU HIS ASP ARG GLY HIS TYR VAL LEU CYS ASP SEQRES 15 B 318 PHE GLY SER ALA THR ASN LYS PHE GLN ASN PRO GLN ALA SEQRES 16 B 318 GLU GLY VAL ASN ALA VAL GLU ASP GLU ILE LYS LYS TYR SEQRES 17 B 318 THR THR LEU SER TYR ARG ALA PRO GLU MET VAL ASN LEU SEQRES 18 B 318 TYR SER GLY LYS ILE ILE THR THR LYS ALA ASP ILE TRP SEQRES 19 B 318 ALA LEU GLY CYS LEU LEU TYR LYS LEU CYS TYR PHE THR SEQRES 20 B 318 LEU PRO PHE GLY GLU SER GLN VAL ALA ILE CYS ASP GLY SEQRES 21 B 318 SER PHE THR ILE PRO ASP ASN SER ARG TYR SER GLN ASP SEQRES 22 B 318 MET HIS CYS LEU ILE ARG TYR MET LEU GLU PRO ASP PRO SEQRES 23 B 318 ASP LYS ARG PRO ASP ILE TYR GLN VAL SER TYR PHE SER SEQRES 24 B 318 PHE LYS LEU LEU LYS LYS GLU CYS PRO VAL PRO ASN VAL SEQRES 25 B 318 GLN ASN SER PRO ILE PRO HET YFS A 401 43 HET SO4 A 402 5 HET YFV B 401 60 HET SO4 B 402 5 HETNAM YFS N-[3-METHOXY-4-(1,3-OXAZOL-5-YL)PHENYL]-D-LEUCINAMIDE HETNAM SO4 SULFATE ION HETNAM YFV 5-[(4-AMINOPIPERIDIN-1-YL)METHYL]-N-{3-[5-(PROPAN-2- HETNAM 2 YFV YL)-1,3,4-THIADIAZOL-2-YL]PHENYL}PYRROLO[2,1-F][1,2, HETNAM 3 YFV 4]TRIAZIN-4-AMINE FORMUL 3 YFS C16 H21 N3 O3 FORMUL 4 SO4 2(O4 S 2-) FORMUL 5 YFV C23 H28 N8 S FORMUL 7 HOH *11(H2 O) HELIX 1 AA1 ASN A 80 LEU A 97 1 18 HELIX 2 AA2 VAL A 134 GLN A 140 1 7 HELIX 3 AA3 THR A 147 GLN A 167 1 21 HELIX 4 AA4 LYS A 178 GLU A 180 5 3 HELIX 5 AA5 GLY A 209 THR A 221 1 13 HELIX 6 AA6 THR A 222 ARG A 226 5 5 HELIX 7 AA7 ALA A 227 ASN A 232 1 6 HELIX 8 AA8 THR A 241 PHE A 258 1 18 HELIX 9 AA9 SER A 265 GLY A 272 1 8 HELIX 10 AB1 SER A 283 LEU A 294 1 12 HELIX 11 AB2 ASP A 303 LYS A 316 1 14 HELIX 12 AB3 ASN B 80 LEU B 97 1 18 HELIX 13 AB4 GLN B 133 GLN B 140 1 8 HELIX 14 AB5 THR B 147 GLN B 167 1 21 HELIX 15 AB6 LYS B 178 GLU B 180 5 3 HELIX 16 AB7 GLY B 209 THR B 221 1 13 HELIX 17 AB8 THR B 222 ARG B 226 5 5 HELIX 18 AB9 ALA B 227 ASN B 232 1 6 HELIX 19 AC1 THR B 241 PHE B 258 1 18 HELIX 20 AC2 SER B 265 GLY B 272 1 8 HELIX 21 AC3 SER B 283 LEU B 294 1 12 HELIX 22 AC4 ASP B 303 LYS B 316 1 14 SHEET 1 AA1 6 VAL A 38 GLY A 40 0 SHEET 2 AA1 6 GLN A 45 GLY A 55 -1 O VAL A 46 N PHE A 39 SHEET 3 AA1 6 ALA A 58 ARG A 64 -1 O LEU A 62 N ASP A 49 SHEET 4 AA1 6 LYS A 70 PHE A 77 -1 O CYS A 71 N VAL A 63 SHEET 5 AA1 6 GLU A 121 ASP A 127 -1 O VAL A 122 N MET A 76 SHEET 6 AA1 6 TYR A 106 ASN A 112 -1 N ASP A 108 O LEU A 125 SHEET 1 AA2 3 GLY A 131 GLN A 133 0 SHEET 2 AA2 3 ILE A 182 LEU A 184 -1 O LEU A 184 N GLY A 132 SHEET 3 AA2 3 TYR A 190 LEU A 192 -1 O VAL A 191 N LEU A 183 SHEET 1 AA3 6 VAL B 38 GLY B 40 0 SHEET 2 AA3 6 GLN B 45 GLY B 55 -1 O VAL B 46 N PHE B 39 SHEET 3 AA3 6 ALA B 58 THR B 65 -1 O LEU B 62 N ASP B 49 SHEET 4 AA3 6 LYS B 70 VAL B 78 -1 O CYS B 71 N VAL B 63 SHEET 5 AA3 6 TRP B 120 ASP B 127 -1 O ILE B 124 N LYS B 74 SHEET 6 AA3 6 TYR B 106 ASN B 112 -1 N ASP B 108 O LEU B 125 SHEET 1 AA4 2 ILE B 182 LEU B 184 0 SHEET 2 AA4 2 TYR B 190 LEU B 192 -1 O VAL B 191 N LEU B 183 CISPEP 1 GLY A 42 ARG A 43 0 -2.01 CISPEP 2 GLY A 236 LYS A 237 0 -3.36 CISPEP 3 SER A 280 ARG A 281 0 12.23 CISPEP 4 GLY B 42 ARG B 43 0 -0.70 SITE 1 AC1 11 ALA A 53 GLU A 54 GLY A 55 ALA A 58 SITE 2 AC1 11 ALA A 72 ASP A 127 CYS A 129 ASN A 181 SITE 3 AC1 11 LEU A 183 CYS A 193 ASP A 194 SITE 1 AC2 5 TYR A 34 ARG A 37 ARG A 75 HOH A 504 SITE 2 AC2 5 GLU B 54 SITE 1 AC3 13 GLN A 45 GLU B 54 GLY B 55 LYS B 74 SITE 2 AC3 13 MET B 126 ASP B 127 PHE B 128 CYS B 129 SITE 3 AC3 13 GLU B 180 ASN B 181 LEU B 183 ASP B 194 SITE 4 AC3 13 HOH B 501 SITE 1 AC4 4 ASN A 67 LYS B 254 THR B 259 LEU B 260 CRYST1 91.514 91.514 172.145 90.00 90.00 120.00 P 31 2 1 12 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.010927 0.006309 0.000000 0.00000 SCALE2 0.000000 0.012618 0.000000 0.00000 SCALE3 0.000000 0.000000 0.005809 0.00000